Protective effects of influenza A (H1N1) pandemic 2009 vaccination against the onset of influenza-like illness and asthma exacerbation in Japanese children

References

• Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009;460:1021–1025
   PubMed Web of Science ®Google Scholar
• Novel Swine-Origin Influenza A(H1N1) Virus Investigation Team. Emergence of a novel swine-origin Influenza A(H1N1) VIRUS IN HUMAns. N Engl J Med 2009;360:2605–2615
   PubMed Web of Science ®Google Scholar
• Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med 2009;361:1935–1944
   PubMed Web of Science ®Google Scholar
• Shimada T, Gu Y, Kamiya H, Komiya N, Odaira F, Sunagawa T, Takahashi H, et al. Epidemiology of influenza A(H1N1) virus infection in Japan. Euro Surveill 2009;14:19244
   PubMedGoogle Scholar
• Pandemic (H1N1) 2009 in Japan, May-September 2009 (Infectious Agents Surveillance Report 30: 255–256, October 2009). Available from: http://idsc.nih.go.jp/iasr/30/356/tpc356.html
   Google Scholar
• Ministry of Health, Labour and Welfare, National Institute of Infectious Diseases. (2010) 2009/10 influenza season, Japan. Infectious Agents Surveillance Report. 31: 248250. Available: http://idsc.nih.go.jp/iasr/31/367/tpc367.html
   Google Scholar
• Nishiura H, Oshitani H. Effects of vaccination against pandemic (H1N1) 2009 among Japanese children [letter]. Emerg Infect Dis 2011;17:746–747
   PubMed Web of Science ®Google Scholar
• Igari H, Segawa S, Watanabe A, Suzuki A, Watanabe M, Sakurai T, Kuroda F, et al. Immunogenicity of a monovalent pandemic influenza A H1N1 vaccine in health-care workers of a university hospital in Japan. Microbiol Immunol 2010;54:618–624
   Google Scholar
• Igari H, Watanabe A, Chiba H, Shoji K, Segawa S, Nakamura Y, Watanabe M, et al. Effectiveness and safety of pandemic influenza A(H1N1)2009 vaccine in healthcare workers at a university hospital in Japan. Jpn J Infect Dis 2011;64:177–182
   PubMed Web of Science ®Google Scholar
• Ohfuji S, Fukushima W, Deguchi M, Kawabata K, Yoshida H, Hatayama H, Maeda A, Hirota Y. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination. J Infect Dis 2011;203:1301–1308
   PubMed Web of Science ®Google Scholar
• Katsunuma T, Matsui T, Iwata T, Nambu M, Kondo N. Hospitalizations associated with pandemic influenza A(H1N1)2009 in asthmatic children in Japan. Allergol Int 2012;61:75–82
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Ohfuji S, Fukushima W, Sugiura S, Kohdera U, Itoh Y, Ide S, et al. Pediatric hospitalizations with influenza A infection during the 2009–2010 pandemic in five hospitals in Japan. Pediatr Int 2012;54:613–618
   PubMed Web of Science ®Google Scholar
• Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, Carlino LO, et al. WHO Working Group for Risk Factors for Severe H1N1pdm infection risk factors for severe outcomes following 2009 Influenza A(H1N1) infection: a global pooled analysis. PLoS Med 2011;8:e1001053
   Google Scholar
• Mahut B, Refabert L, Marchac V, Iniguez JL, Aubertin G, Tamalet A, Lebras MN, et al. Influenza-like illness responsible for severe exacerbations in asthmatic children during H1N1 pandemic: a survey before vaccination. J Asthma 2011;48:224–227
   PubMed Web of Science ®Google Scholar
• Santillan Salas CF, Mehra S, Pardo Crespo MR, Juhn YJ. Asthma and severity of 2009 novel H1N1 influenza: a population-based case-control study. J Asthma 2013;50:1069–1076
   PubMed Web of Science ®Google Scholar
• Kloepfer KM, Olenec JP, Lee WM, Liu G, Vrtis RF, Roberg KA, Evans MD, et al. Increased H1N1 infection rate in children with asthma. Am J Respir Crit Care Med 2012;185:1275–1279
   PubMed Web of Science ®Google Scholar
• Yin JK, Chow MY, Khandaker G, King C, Richmond P, Heron L, Booy R. Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses. Vaccine 2012;30:3209–3222
   PubMed Web of Science ®Google Scholar
• Johansen K, Nicoll A, Ciancio BC, Kramarz P. Pandemic influenza A(H1N1) 2009 vaccines in the European Union. Euro Surveill 2009;14:19361
   PubMedGoogle Scholar
• Mahmud S, Hammond G, Elliott L, Hilderman T, Kurbis C, Caetano P, Van Caeseele P, et al. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study. Vaccine 2011;29:7975–7981
   PubMed Web of Science ®Google Scholar
• Griffin MR, Monto AS, Belongia EA, Treanor JJ, Chen Q, Chen J, Talbot HK, et al; U.S. Flu-VE Network. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One 2011;6:e23085
   PubMed Web of Science ®Google Scholar
• Hardelid P, Fleming DM, Andrews N, Barley M, Durnall H, Mangtani P, Pebody R, et al. Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008–2010: results from a cohort study in general practice. Vaccine 2012;30:1371–1378
   PubMedGoogle Scholar
• Hadler JL, Baker TN, Papadouka V, France AM, Zimmerman C, Livingston KA, Zucker JR. Effectiveness of 1 dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children aged 7 months-9 years. J Infect Dis 2012;206:49–55
   PubMed Web of Science ®Google Scholar
• Uzicanin A, Thompson M, Smith P, Chaves SS, Foster L, Dube N, Graitcer S, et al; Maine 2009 Influenza A (H1N1) Vaccine Effectiveness Evaluation Group. Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in Maine. J Infect Dis 2012;206:1059–1068
   PubMed Web of Science ®Google Scholar
• Thompson MG, Sokolow LZ, Almendares O, Openo K, Farley MM, Meek J, Ray J, et al. Effectiveness of nonadjuvanted monovalent influenza A(H1N1)pdm09 vaccines for preventing reverse transcription polymerase chain reaction-confirmed pandemic influenza hospitalizations: case-control study of children and adults at 10 US influenza surveillance network sites. Clin Infect Dis 2013;57:1587–1592
   PubMed Web of Science ®Google Scholar
• Cheng AC, Kotsimbos T, Kelly HA, Irving LB, Bowler SD, Brown SG, Holmes M, et al. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study. Vaccine 2011;29:7320–7325
   PubMed Web of Science ®Google Scholar
• Lim J, Choi B, Kim J, Kim C, Park J, Yoon H, et al. Evaluation and sensitivity analysis of the effectiveness of unadjuvanted A(H1N1)pdm09 vaccine in hospital workers using multi-center cohort study in Korea. Vaccine 2013;31:2381–2386
   PubMed Web of Science ®Google Scholar
• Cuhaci Çakir B, Beyazova U, Kemaloğlu YK, Özkan S, Gündüz B, Özdek A. Effectiveness of pandemic influenza A/H1N1 vaccine for prevention of otitis media in children. Eur J Pediatr 2012;171:1667–1671
   PubMed Web of Science ®Google Scholar
• Simpson CR, Ritchie LD, Robertson C, Sheikh A, McMenamin J. Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study. Lancet Infect Dis 2012;12:696–702
   PubMed Web of Science ®Google Scholar
• Hellenbrand W, Jorgensen P, Schweiger B, Falkenhorst G, Nachtnebel M, Greutélaers B, Traeder C, Wichmann O. Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009–2010 using matched hospital and test-negative controls. BMC Infect Dis 2012;12:127
   PubMed Web of Science ®Google Scholar
• Emborg HD, Krause TG, Hviid A, Simonsen J, Mølbak K. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009–10. BMJ 2011;344:d7901
   Google Scholar
• Savulescu C, Jiménez-Jorge S, de Mateo S, Pozo F, Casas I, Breña PP, Galmés A, et al. Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009–2010. BMC Public Health 2011;11:899
   PubMed Web of Science ®Google Scholar
• Seyler T, Bella A, Puzelli S, Donatelli I, Rizzo C; screening method working group. Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009–2010. Vaccine 2012;30:109–111
   PubMed Web of Science ®Google Scholar
• Lee VJ, Tan CH, Yap J, Cook AR, Ting PJ, Loh JP, Gao Q, et al. Effectiveness of pandemic H1N1-2009 vaccination in reducing laboratory confirmed influenza infections among military recruits in tropical Singapore. PLoS One 2011;6:e26572
   Web of Science ®Google Scholar
• Italian Multicenter Study Group for Drug and Vaccine Safety in Children. Effectiveness and safety of the A-H1N1 vaccine in children: a hospital-based case-control study. BMJ Open 2011;1:e000167
   Web of Science ®Google Scholar
• Gilca R, Deceuninck G, De Serres G, Boulianne N, Sauvageau C, Quach C, Boucher FD, Skowronski DM. Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children. Pediatrics 2011;128:e1084–e1091
   Web of Science ®Google Scholar
• Castilla J, Morán J, Martínez-Artola V, Fernández-Alonso M, Guevara M, Cenoz MG, Reina G, et al; Primary Health Care Sentinel Network of Navarre. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009–2010: cohort and case-control study. Vaccine 2011;29:5919–5924
   PubMed Web of Science ®Google Scholar
• Pelat C, Falchi A, Carrat F, Mosnier A, Bonmarin I, Turbelin C, Vaux S, et al. Field effectiveness of pandemic and 2009–2010 seasonal vaccines against 2009–2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS One 2011;6:e19621
   PubMed Web of Science ®Google Scholar
• Estimates of pandemic influenza vaccine effectiveness in Europe, 2009–2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med 2011;8:e1000388
   Google Scholar
• Hardelid P, Fleming DM, McMenamin J, Andrews N, Robertson C, SebastianPillai P, Ellis J, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009–2010. Euro Surveill 2011;16:19763
   PubMedGoogle Scholar
• Song JY, Cheong HJ, Heo JY, Noh JY, Choi WS, Park DW, Lee J, et al. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea. Vaccine 2011;29:1395–1398
   PubMed Web of Science ®Google Scholar
• Wu J, Xu F, Lu L, Lu M, Miao L, Gao T, Ji W, et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med 2010;363:2416–2423
   PubMed Web of Science ®Google Scholar
• Puig-Barberà J, Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, Pérez-Vilar S, Silvestre-Silvestre E, Calvo-Mas C, et al; Surveillance and Vaccine Evaluation Group during the autumn 2009 H1N1 pandemic wave in Castellón, Spain. Effectiveness of seasonal 2008–2009, 2009–2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. Vaccine 2010;28:7460–7467
   PubMed Web of Science ®Google Scholar
• Borse RH, Shrestha SS, Fiore AE, Atkins CY, Singleton JA, Furlow C, Meltzer MI. Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009–2010. Emerg Infect Dis 2013;19:439–448
   PubMed Web of Science ®Google Scholar
• Obuchi M, Adachi Y, Takizawa T, Sata T. Influenza A(H1N1)pdm09 virus and asthma. Front Microbiol 2013;4:307
   PubMed Web of Science ®Google Scholar
• Busse WW, Peters SP, Fenton MJ, Mitchell H, Bleecker ER, Castro M, Wenzel S, et al. Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine. J Allergy Clin Immunol 2011;127:130–137
   PubMed Web of Science ®Google Scholar
• Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, Foust A, Lindstrom S, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004–2005 season to the 2006–2007 season. J infect Dis 2009;199:159–167
   PubMed Web of Science ®Google Scholar
• Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med 2012;156:500–511
   PubMed Web of Science ®Google Scholar
• Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, Williams H; ISAAC Phase Three Study Group, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733–743
   PubMed Web of Science ®Google Scholar
• Santillan Salas CF, Mehra S, Pardo Crespo MR, Juhn YJ. Atopic conditions other than asthma and risk of the 2009 novel H1N1 infection in children: a case-control study. Allergy Asthma Proc 2013;34:459–466
   PubMed Web of Science ®Google Scholar